Peculiarities of the clinical course and pathomorphological picture of ovarian endometriosis and adenomyosis in reproductive aged women

In: REPRODUCTIVE ENDOCRINOLOGY · 2022 · pp. 23–28 · doi:10.18370/2309-4117.2022.65.23-28 · W4307173905
article OA: diamond CC0
AI-generated summary by claude@2026-06, 2026-06-07

This study examined 87 reproductive-aged women with ovarian endometriosis or adenomyosis, finding frequent concurrent gynecological and extragenital pathologies, a history of reproductive losses, and specific pathomorphological changes impacting ovarian reserve and uterine function.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-07 · read from full text

This study assessed clinical and pathomorphological features of ovarian endometriosis and adenomyosis in 87 reproductive-aged women, comparing 45 patients with adenomyosis (with or without concomitant pathology) to 42 women with ovarian endometriomas, with 30 healthy women as controls; all underwent endoscopic treatment (laparoscopy/hysteroscopy) and subsequent morphological examination. The authors found frequent gynecological and extragenital comorbidities and a burdened obstetric/gynecologic history, while histology showed features of endometrioid cyst structure linked to decreased ovarian reserve, reactive hyperplasia, chronic endometritis, active adenomyosis, and uterine cavity distortion by fibroids, potentially affecting implantation and placentation. As a limitation, the paper provides observational clinical and morphological associations within a specific reproductive-age cohort without stating systematic control for all confounders. This paper is centrally about endometriosis and adenomyosis — it analyzes clinical course and histopathological mechanisms in ovarian endometriosis and adenomyosis in reproductive-aged women.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Оbjectives: to assess the clinical and pathomorphological features of ovarian endometriosis and adenomyosis in women of reproductive age in order to determine possible causes of fertility disorders and ways to correct them.Materials and methods. 87 patients were examined and divided into 2 groups. The first group included 45 (51.7%) patients with adenomyosis with or without concomitant pathology. The second group included 42 (48.3%) women with ovarian endometriomas. The control group consisted of 30 healthy women of childbearing age who were screened for male infertility.Results. Clinical examination of the patients revealed a high frequency of gynecological (uterine fibroids, endometrial hyperplasia, infertility) and extragenital pathology. Obstetric and gynecological history was burdened by reproductive losses (involuntary and medical abortions, ectopic pregnancy), premature birth, preeclampsia, abnormal uterine and obstetric bleeding, and pelvic surgery. All patients underwent endoscopic treatment (laparoscopy, hysteroscopy). Morphological examination revealed features of the structure of endometrioid cysts, which explains the decrease in ovarian reserve, active adenomyosis, reactive hyperplasia and chronic endometritis, distortion of the uterine cavity by fibroids. This may play an important role in implantation and placentation.Conclusions. Features of morphogenesis of ovarian endometrioma, found by us cystic and glandular-cystic forms may form the basis of endometrial microperforation pathogenesis, development of adhesions of the pelvic organs (in every third woman), ectopic pregnancy, fibrotic adjacent endometrioid tissue and reduction of ovarian reserve. The peculiarities of the uterus histostructure in adenomyosis, frequent combination with uterine fibroids, endometrial hyperplasia, chronic endometritis, ovarian endometriosis, deep infiltrative endometriosis, old age, aggravated obstetric anamnesis and the history of obstetric disorders may be related.
Full text 9,393 characters · extracted from oa-doi-fallback · 2 sections · click to expand

Materials

and methods. 87 patients were examined and divided into 2 groups. The first group included 45 (51.7%) patients with adenomyosis with or without concomitant pathology. The second group included 42 (48.3%) women with ovarian endometriomas. The control group consisted of 30 healthy women of childbearing age who were screened for male infertility. Results. Clinical examination of the patients revealed a high frequency of gynecological (uterine fibroids, endometrial hyperplasia, infertility) and extragenital pathology. Obstetric and gynecological history was burdened by reproductive losses (involuntary and medical abortions, ectopic pregnancy), premature birth, preeclampsia, abnormal uterine and obstetric bleeding, and pelvic surgery. All patients underwent endoscopic treatment (laparoscopy, hysteroscopy). Morphological examination revealed features of the structure of endometrioid cysts, which explains the decrease in ovarian reserve, active adenomyosis, reactive hyperplasia and chronic endometritis, distortion of the uterine cavity by fibroids. This may play an important role in implantation and placentation. Conclusions. Features of morphogenesis of ovarian endometrioma, found by us cystic and glandular-cystic forms may form the basis of endometrial microperforation pathogenesis, development of adhesions of the pelvic organs (in every third woman), ectopic pregnancy, fibrotic adjacent endometrioid tissue and reduction of ovarian reserve. The peculiarities of the uterus histostructure in adenomyosis, frequent combination with uterine fibroids, endometrial hyperplasia, chronic endometritis, ovarian endometriosis, deep infiltrative endometriosis, old age, aggravated obstetric anamnesis and the history of obstetric disorders may be related.

References

- Bakun, O.V., Tkachuk, A.I. “Influence of genital endometriosis and concomitant diseases on infertility under the data of the retrospective analysis of case histories.” Bukovinian Medical Herald 4.92 (2019): 9–15. - Vorobii, V.D. “Characteristcs of the course of pregnancy and labor in women with endometriosis.” Actual problems of modern medicine: Bulletin of the Ukrainian Medical Stomatological Academy 18.3 (63) (2018): 44–7. - Zaporozhan, V.M., Gladchuk, I.Z., Rozhkovska, N.M., et al. “New technologies in surgical treatment of deep infiltrative and superficial peritoneal endometriosis.” Reproductive endocrinology 2.16 (2014): 7–9. - Zaporozhan, V.M., Tatarchuk, T.P., Kaminskyi, V.V., et al. “National consensus on management patients with endometriosis.” Reproductive endocrinology 4.24 (2015): 7–12. - Koval, G.D. “IL-17 in women with endometriosis combined with infertility.” Immunology and allergology: science and practice 1 (2013): 76–79. - Medvedіev, M.V., Pokrovenko, D.A. “A modern view of the etiology, pathogenesis and diagnostic possibilities of external genital endometriosis (literature review).” Medical perspectives 24.1 (2019): 21–30. DOI: 10.26641/2307-0404.2019.1.162173 - Sytnikova, V.O., Rosha, L.H., Honcharenko, H.Y. “Clinical and morphological features of the course of internal endometriosis in combination with endometrioid carcinoma of the endometrium in postmenopausal women.” Science Review 3.2.9 (2018): 58–60. - Acién, P., Velasco, I. “Endometriosis: a disease that remains enigmatic.” ISRN Obstet Gynecol 2013 (2013): 242149. DOI: 10.1155/2013/242149 - Agarwal, S.K., Chapron, C., Giudice, L.C., et al. “Clinical diagnosis of endometriosis: a call to action.” Am J Obstet Gynecol 4 (2019): 354–64. - Amalinei, C., Păvăleanu, I., Lozneanu, L., et al. “Endometriosis – insights into a multifaceted entity.” Folia Histochem Cytobiol 1.2 (2018): 61–82. DOI: 10.5603/FHC.a2018.0013 - Augoulea, A., Alexandrou, A., Creatsa, M., et al. “Pathogenesis of endometriosis: the role of genetics, inflammation and oxidative stress.” Arch Gynecol Obstet 286.1 (2012): 99–103. DOI: 10.1007/s00404-012-2357-8 - Brosens, I., Gordts, S., Benagiano, G. “Endometriosis in adolescents is a hidden, progressive and severe disease that deserves attention, not just compassion.” Hum Reprod 28 (2013): 2026–31. - Cakmak, H., Guzeloglu-Kayisli, O., Kayisli, U.A., Arici, A. “Immune-endocrine interactions in endometriosis.” Front Biosci (Elite Ed) 1 (2009): 429–43. - Zondervan, K.T., Becker, C.M., Missmer, S.A. “Endometriosis.” N Engl J Med 382.13 (2020): 1244–56. DOI: 10.1056/NEJMra1810764 - Cranney, R., Condous, G., Reid, S. “An update on the diagnosis, surgical management, and fertility outcomes for women with endometrioma.” Acta Obstet Gynecol Scand 96 (2017): 633–43. DOI: 10.1111/aogs.13114 - Dahiya, A., Sebastian, A., Thomas, A., et al. “Endometriosis and malignancy: The intriguing relationship.” Int J Gynaecol Obstet 155.1 (2021): 72–8. DOI: 10.1002/ijgo.13585 - ESHRE. “ESHRE guideline: endometriosis.” Hum Reprod Open 2022.2 (2022): hoac009. DOI: 10.1093/hropen/hoac009 - Fang, Z., Yang, S., Lydon, J.P., et al. “Intact progesterone receptors are essential to counteract the proliferative effect of estradiol in a genetically engineered mouse model of endometriosis.” Fertil Steril 82.3 (2004): 673–8. DOI: 10.1016/j.fertnstert.2004.01.048 - Guerriero, S., Condous, G., van den Bosch, T., et al. “Systematic approach to sonographic evaluation of the pelvis in women with suspected endometriosis, including terms, definitions and measurements: a consensus opinion from the International Deep Endometriosis Analysis (IDEA) group.” Ultrasound Obstet Gynecol 48.3 (2016): 318–32. - Giudice, L.C. “Clinical practice. Endometriosis.” N Engl J Med 362.25 (2010): 2389–98. DOI: 10.1056/NEJMcp1000274 - Johnson, N.P., Hummelshoj, L., Adamson, G.D., et al. “World Endometriosis Society consensus on the classification of endometriosis.” Hum Reprod 32.2 (2017): 315–24. - Khan, K.N., Kitajima, M., Inoue, T., et al. “17β-estradiol and lipopolysaccharide additively promote pelvic inflammation and growth of endometriosis.” Reprod Sci 22.5 (2015): 585–94. DOI: 10.1177/1933719114556487 - Macer, M.L., Taylor, H.S. “Endometriosis and infertility: a review of the pathogenesis and treatment of endometriosis-associated infertility.” Obstet Gynecol Clin North Am 39.4 (2012): 535–49. DOI: 10.1016/j.ogc.2012.10.002 - Martire, F.G., Lazzeri, L., Conway, F., et al. “Adolescence and endometriosis: symptoms, ultrasound signs and early diagnosis.” Fertil Steril 114.5 (2020): 1049–57. - Menakaya, U., Reid, S., Lu, C., et al. “Performance of an Ultrasound Based Endometriosis Staging System (UBESS) for predicting the level of complexity of laparoscopic surgery for endometriosis.” Ultrasound Obstet Gynecol 48 (2016): 786–95. - Mikos, T., Lioupis, M., Anthoulakis, C., Grimbizis, G.F. “The Outcome of Fertility-Sparing and Nonfertility-Sparing Surgery for the Treatment of Adenomyosis. A Systematic Review and Meta-analysis.” J Minim Invasive Gynecol 27 (2020): 309. - Robboy, S.J., Bean, S.M. “Pathogenesis of endometriosis.” Reprod Biomed Online 21.1 (2010): 4–5. DOI: 10.1016/j.rbmo.2010.03.031 - Rolla, E. “Endometriosis: advances and controversies in classification, pathogenesis, diagnosis, and treatment.” F1000Research 8 (2019): F1000 Faculty Rev-529. DOI: 10.12688/f1000research.14817.1 - Rozhkovskaya, N.M., Sitnikova, V.O., Sivyi, S.M., Lomakina, I.S. “Clinical and morphological features of combined hyperplastic diseases of the uterus against the background of adenomyosis.” Journal of education health and sport 10.4 (2020): 226–33. DOI: 10.12775/JEHS.2020.10.04.025 - Singh, S.S., Suen, M.W. “Surgery for endometriosis: beyond medical therapies.” Fertil Steril 107.3 (2017): 549–54. DOI: 10.1016/j.fertnstert.2017.01.001 - World Health Organization. International Classification of Diseases, 11th Revision (ICD-11). Geneva: WHO (2018). - Wu, Q., Lian, Y., Chen, L., et al. “Alleviation of Symptoms and Improvement of Endometrial Receptivity Following Laparoscopic Adenomyoma Excision and Secondary Therapy with the Levonorgestrel-releasing Intrauterine System.” Reprod Sci 27.6 (2020): 1259–65. Downloads Published How to Cite Issue Section License Copyright (c) 2022 І.З. Гладчук, Н.М. Рожковська, В.О. Ситнікова, І.В. Шпак, С.М. Сивий This work is licensed under a Creative Commons Attribution 4.0 International License. Authors who publish with this journal agree to the following terms: - Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. - Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisadenomyosisendometriomainfertility

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (28)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK